Guidance on applications for COVID-19 drug...
Dataset description:
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 20, 2025 |
| Metadata last updated | October 20, 2025 |
| Created | October 20, 2025 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | 447edbf7-c6ce-4e26-868d-e9c653073223 |
| Package id | 49f35964-600e-4bcd-aba8-4ac4497f3392 |
| Position | 1 |
| State | active |